Page last updated: 2024-11-03

probenecid and Gall Bladder Diseases

probenecid has been researched along with Gall Bladder Diseases in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaye, D1
Merselis, JG1
Connolly, S1
Hook, EW1

Other Studies

1 other study available for probenecid and Gall Bladder Diseases

ArticleYear
Treatment of chronic enteric carriers of Salmonella typhosa with ampicillin.
    Annals of the New York Academy of Sciences, 1967, Sep-27, Volume: 145, Issue:2

    Topics: Administration, Oral; Adult; Aged; Ampicillin; Carrier State; Feces; Female; Gallbladder Diseases; H

1967